Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial
Related Posts
Makaroff KE, Van C, Grospe V, Edmunds L, Calfon-Press MA, Watson KE, Horwich T. Novel Virtual Reality Intervention for Stress Reduction Among Patients With or[...]
Liu Z, Aguayo E, Porter G, Ali K, Zinoviev R, Benharash P. Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve[...]
Baskaran L, Dutta U, Xiaomeng W, Gray MP, Chan M, Branch K, Budoff M, Blankstein R, Douglas PS, Figtree GA. Accelerating Drug Translation: Role of[...]